The Facility Fee Gravy Train Is Over: How CMS's 2026 Site-Neutral Rules Will Unwind a Decade of Hospital-Employed Physician Deals

The financial architecture of hospital physician employment was always more fragile than it looked. For a decade, health systems justified the staggering cost of acquiring independent practices — a median operating loss of $317,409 per physician FTE as of Q2 2025, per Kaufman Hall — by pointing to the facility fee premium baked into Hospital Outpatient Department (HOPD) billing. CMS's 2026 site-neutral finalized rules don't just trim that premium; they structurally dismantle it. The consequence for employed physicians isn't abstract: it's a renegotiation of the contract terms, compensation benchmarks, and organizational logic that governed the entire hospital employment model.

What Site-Neutral Actually Means — and Why Hospitals Fought So Hard Against It

Site-neutral payment is a deceptively simple concept. Medicare pays dramatically different rates for identical clinical services depending on whether they're delivered in a hospital outpatient department or a freestanding physician office. Drug administration services — infusions, chemotherapy, biologic injections — were reimbursed at 129 to 211 percent higher rates in HOPDs than in freestanding physician offices as recently as 2021. Preventive office visits ran 51 percent higher in the HOPD setting as of 2023.

Beginning January 1, 2026, CMS finalized a 60% rate reduction for drug administration services at off-campus provider-based departments, paying them instead at 40% of the applicable OPPS rate — effectively the physician fee schedule equivalent. CMS estimates $290 million in 2026 savings from this rule alone, $220 million recovered by Medicare and $70 million passed to beneficiaries through reduced coinsurance. Over 2026-2035, comparable drug administration reforms are projected to save $8 billion cumulatively.

Hospitals fought this for years precisely because the stakes are existential. The American Hospital Association immediately condemned the final rule, warning of compounding financial pressures on already-strained balance sheets. But the full scope of what CMS could still do dwarfs the 2026 action: broader site-neutrality — aligning all commonly-provided physician office services across HOPDs — could save $157 billion over a decade. CMS has opened the door, and the directional signal from the Trump administration is unambiguous.

The Acquisition Math No Longer Works: How Health Systems Built Revenue on the HOPD Premium

To understand why this is so destabilizing, consider the financial logic hospitals used to justify acquiring physician practices. When a hospital purchases a physician group and converts its billing to an HOPD designation, it captures two revenue streams per patient encounter: the professional fee (physician work) and the facility fee (hospital overhead charges). Combined, these generally exceeded what the same physician could bill independently under the Medicare Physician Fee Schedule. This wasn't incidental — it was the entire business case.

Hospital ownership of physician practices jumped from 39% to 59% of all U.S. practices between 2019 and 2023, per PMC research. The Niskanen Center documented how this consolidation widened price gaps in commercial markets as hospitals leveraged acquisition-driven scale in insurer negotiations. The facility fee wasn't a rounding error; it was the economic justification for paying above-market acquisition multiples on physician practices.

With CMS systematically closing the HOPD rate gap, the net revenue yield from employed physicians in off-campus departments falls materially. Health systems that paid goodwill premiums to acquire practices now hold assets generating substantially less marginal revenue than when the deals were originally underwritten.

Employed Physicians Are Now a Liability Center, Not a Profit Center

The 2026 Physician Fee Schedule final rule applies a second layer of pressure through its practice expense (PE) RVU reallocation. Facility-based services face approximately a 7% aggregate payment decrease while office-based care receives roughly a 4% increase, per Revele MD's spring 2026 analysis. Simultaneously, the rule implements a 2.5% efficiency adjustment reducing work RVUs for roughly 7,000 non-time-based CPT codes — surgeries, diagnostics, imaging, interventional procedures — representing over 90% of Medicare physician volume.

For a hospital-employed cardiologist generating 10,000 wRVUs annually with 80% procedural volume, ChiroKhealth estimates a loss of approximately 800 wRVUs. At a $33.40 conversion factor, that's roughly $6,680 in direct annual compensation erosion from the wRVU adjustment alone — before the PE reallocation penalty layers on top. High-volume surgeons may lose $20,000-$40,000 in effective compensation without changing their clinical behavior in any way.

Health systems were already hemorrhaging on physician employment. Kaufman Hall reported median subsidies per physician FTE at $317,409 in Q2 2025, an 8% increase over two years, while net patient revenue per wRVU dipped 7% since 2023 even as physician productivity rose 6%. These organizations cannot absorb an additional 7-10% payment compression on facility-based services without triggering structural changes to physician compensation.

Contract Provisions to Watch: Where Compensation Clawbacks and RVU Resets Are Hidden

The contracts most at risk are standard wRVU productivity models with static thresholds. When a physician's wRVU output appears to drop 2.5% because CMS reduced the valuations — not because the physician saw fewer patients or performed fewer procedures — any contract measuring bonus eligibility against a fixed wRVU threshold delivers an automatic pay cut. PYA's compensation planning analysis identifies the downstream risks: distorted bonus outcomes, inequity across specialties, and retention failures concentrated in exactly the high-volume procedural specialties hospitals most need.

Organizations must audit every employment agreement referencing "wRVU," "CMS RVU schedule," or "productivity threshold." Systems that don't proactively adjust thresholds or per-unit rates to account for the efficiency adjustment will trigger physician grievances and, in competitive markets, departures. Signing bonus clawback provisions — often structured with 12% annual interest penalties over 5-year terms in aggressive contracts — add further complexity for physicians evaluating any employment transition. The physicians most likely to face clawback exposure are procedural specialists, the same cohort whose wRVU output the 2026 rules most directly penalize.

The Freestanding Clinic Arbitrage Window Is Open — But Only Briefly

The same 2026 final rule that penalizes facility-based care explicitly rewards office-based delivery. A 4% PE increase for independent office settings, combined with the narrowing HOPD payment gap, creates a quantifiable financial argument for physician independence that hasn't existed at this scale in years. The Niskanen Center notes that site-neutral reforms directly reduce the incentive for hospital acquisition by closing the arbitrage that made HOPD conversion profitable in the first place.

Physicians evaluating a transition to freestanding models should move quickly. The window is real, but commercial payer contracts — which often lag Medicare policy by 12-18 months and may contain their own facility-fee differential language — will eventually close. Physicians who establish freestanding economics at scale in 2026 and 2027 will hold a structural cost advantage over those who wait for commercial alignment to catch up.

What Practice Administrators Should Be Modeling Right Now

Before the next budget cycle closes, administrators and CFOs should run three specific analyses. First, map the 2026 PE reallocation impact by service line and site of service across every employed physician contract. Second, stress-test all wRVU threshold-based compensation structures against a 2.5% reduction in wRVU output to identify which physicians face unintended pay cuts beginning January 1. Third, model the net margin differential between maintaining off-campus HOPD designation versus converting ambulatory services to freestanding office billing under the updated rate structure.

Health systems that treat 2026 as a routine OPPS update are underestimating what is structurally different this time. CMS has applied site-neutral logic to a new service category, established a 0.5% annual OPPS conversion factor reduction starting in 2026 with explicit signals of up to 2% reductions in 2027, and simultaneously restructured physician PE allocations to disadvantage facility-based care. The organizations that restructure compensation agreements and realign clinical delivery sites proactively will absorb this transition. Those that don't will face a wave of physician contract disputes — and departures — when the numbers come due.